MedElevator Войти в исследования
← Поиск публикаций

DOI 10.7554/elife.95185

Медицинская библиотека · eLife · 2024

Evaluation of Gremlin-1 as a therapeutic target in metabolic dysfunction-associated steatohepatitis.

Horn Paul, Norlin Jenny, Almholt Kasper, Viuff Birgitte M, Galsgaard Elisabeth D, Hald Andreas, Zosel Franziska, Demuth Helle, Poulsen Svend, Norby Peder L, Rasch Morten G, Vyberg Mogens, Fleckner Jan, Werge Mikkel Parsberg, Gluud Lise Lotte, Rink Marco R, Shepherd Emma, Northall Ellie, Lalor Patricia F, Weston Chris J, Fog-Tonnesen Morten, Newsome Philip N

СтатьяПеревод пока не подготовлен

Аннотация

Gremlin-1 has been implicated in liver fibrosis in metabolic dysfunction-associated steatohepatitis (MASH) via inhibition of bone morphogenetic protein (BMP) signalling and has thereby been identified as a potential therapeutic target. Using rat in vivo and human in vitro and ex vivo model systems of MASH fibrosis, we show that neutralisation of Gremlin-1 activity with monoclonal therapeutic antibodies does not reduce liver inflammation or liver fibrosis. Still, Gremlin-1 was upregulated in human and rat MASH fibrosis, but expression was restricted to a small subpopulation of COL3A1/THY1+ myofibroblasts. Lentiviral overexpression of Gremlin-1 in LX-2 cells and primary hepatic stellate cells led to changes in BMP-related gene expression, which did not translate to increased fibrogenesis. Furthermore, we show that Gremlin-1 binds to heparin with high affinity, which prevents Gremlin-1 from entering systemic circulation, prohibiting Gremlin-1-mediated organ crosstalk. Overall, our findings suggest a redundant role for Gremlin-1 in the pathogenesis of liver fibrosis, which is unamenable to therapeutic targeting.

Для цитирования: Horn Paul, Norlin Jenny, Almholt Kasper, Viuff Birgitte M, Galsgaard Elisabeth D, Hald Andreas, Zosel Franziska, Demuth Helle, Poulsen Svend, Norby Peder L, Rasch Morten G, Vyberg Mogens, Fleckner Jan, Werge Mikkel Parsberg, Gluud Lise Lotte, Rink Marco R, Shepherd Emma, Northall Ellie, Lalor Patricia F, Weston Chris J, Fog-Tonnesen Morten, Newsome Philip N. Evaluation of Gremlin-1 as a therapeutic target in metabolic dysfunction-associated steatohepatitis.. eLife. 2024. DOI: 10.7554/elife.95185.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.